Morin underscored that generic substitution should be a given for any plan, yet some still lack it
Glycemic control and treatment failure with pioglitazone versus glibenclamide in type 2 diabetes mellitus: a 42-month, open-label, observational, primary care study
The results of the TIMES project confirmed the differentiated characteristics of imeglimin, showing that imeglimin has a dual mechanism of action to increase insulin secretion and improve insulin sensitivity, and it shows an increased hypoglycemic effect when combined with drugs with complementary mechanisms of action, including DPP-4 inhibition Agents, SGLT2 inhibitors, biguanides, sulfonylurea drugs, gleneides, alpha-glucosidase inhibitors, thiazolidine drugs, GLP1 receptor agonists
Wegovy got that approval in 2024)
Head, K
Despite changes in the prevalence of cardiovascular diseases and their risk factors (including lipid disorders) observed in Poland between the year 1990 and 2017, differences between Poland and Western Europe remain very high [29]
